Indan-5-amine → HCID 136337178, 화합물
반응식
C1C2C(=CC(N)=CC=2)CC1.[CH2:11]([O:13][C:14]([C:16]1[CH:17]=[N:18][N:19]([C:21]2[NH:30][C:29](=[O:31])[C:28]3[C:27]4[CH2:32][CH2:33][CH2:34][C:26]=4[CH:25]=[CH:24][C:23]=3[N:22]=2)[CH:20]=1)=[O:15])[CH3:12]>>[CH2:11]([O:13][C:14]([C:16]1[CH:17]=[N:18][N:19]([C:21]2[NH:30][C:29](=[O:31])[C:28]3[C:23](=[CH:24][C:25]4[CH2:32][CH2:33][CH2:34][C:26]=4[CH:27]=3)[N:22]=2)[CH:20]=1)=[O:15])[CH3:12]참가 물질
3
실험 절차
The titled compound was prepared in a manner analogous to Example 131, steps A-B, using indan-5-ylamine in step A. Step B yielded a 10:1 mixture of the titled compound and 1-(1-oxo-2,7,8,9-tetrahydro-1H-cyclopenta[f]quinazolin-3-yl)-1H-pyrazole-4-carboxylic acid ethyl ester.
후처리
- customThe titled compound was prepared in a manner analogous to Example 131, steps A-B
- customStep B yielded
출처 및 근거
- ORD 기록
- ord-bea0d73b47a947b294bec0980bd72683
- 출처 데이터셋
- uspto-grants-2015_01
- 특허 번호
- US08937078B2
반응 노트
불러오는 중…